Genomic Valley Biotech Ltd vs Khandelwal Extractions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 13, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 24.99 as of 13 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 yearsThe P/E Ratio of Khandelwal Extractions Ltd changed from 10 on March 2022 to 23.9 on March 2025 . This represents a CAGR of 24.34% over 4 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 yearsThe Market Cap of Khandelwal Extractions Ltd changed from ₹ 0.89 crore on March 2021 to ₹ 6.82 crore on March 2025 . This represents a CAGR of 50.27% over 5 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of Khandelwal Extractions Ltd for the Dec '25 is ₹ 0.18 crore as compare to the Sep '25 revenue of ₹ 0.2 crore. This represent the decline of -10% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Khandelwal Extractions Ltd for the Dec '25 is ₹ 0.06 crore as compare to the Sep '25 ebitda of ₹ 0.08 crore. This represent the decline of -25% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of Khandelwal Extractions Ltd changed from ₹ 0.12 crore to ₹ 0.04 crore over 7 quarters. This represents a CAGR of -46.62% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Khandelwal Extractions Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Khandelwal Extractions Ltd

Khandelwal Extractions Limited was incorporated on 24 April, 1981 as a Private Limited Company with the promoter; Anil Khandelwal.
The Company got converted to a Public Limited Company on 26 May, 1982.The Company is primarily engaged in manufacturing and sale of solvent oil. The Company's solvent extraction operations were closed from November 2018. The Company has closed its present operations of manufacturing of rice bran oil/de-oiled rice bran in 2021. In 2022, the Company sold Plant & Machinery, Stores and Spares of the Company and leased out all its godowns at Akrampur-Magarwara, Distt.
Unnao.

FAQs for the comparison of Genomic Valley Biotech Ltd and Khandelwal Extractions Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Khandelwal Extractions Ltd?

Market cap of Genomic Valley Biotech Ltd is 7 Cr while Market cap of Khandelwal Extractions Ltd is 10 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Khandelwal Extractions Ltd?

The stock performance of Genomic Valley Biotech Ltd and Khandelwal Extractions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Khandelwal Extractions Ltd?

As of March 13, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹24.99. On the other hand, Khandelwal Extractions Ltd stock price is INR ₹117.65.

How do dividend payouts of Genomic Valley Biotech Ltd and Khandelwal Extractions Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Khandelwal Extractions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.